147 related articles for article (PubMed ID: 12009420)
1. On the regulatory role of dipeptidyl peptidase IV (=CD=adenosine deaminase complexing protein) on adenosine deaminase activity.
Ben-Shooshan I; Kessel A; Ben-Tal N; Cohen-Luria R; Parola AH
Biochim Biophys Acta; 2002 May; 1587(1):21-30. PubMed ID: 12009420
[TBL] [Abstract][Full Text] [Related]
2. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
4. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
5. The CP-I subunit of adenosine deaminase complexing protein from calf kidney is identical to human, mouse, and rat dipeptidyl peptidase IV.
Ben-Shooshan I; Parola AH
Comp Biochem Physiol B Biochem Mol Biol; 1998 Feb; 119(2):289-92. PubMed ID: 9629661
[TBL] [Abstract][Full Text] [Related]
6. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD
Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373
[TBL] [Abstract][Full Text] [Related]
7. Citrullination of adenosine deaminase impairs its binding to dipeptidyl peptidase IV.
Karapetyan L; Sharoyan S; Mardanyan S; Lupidi G; Cuccioloni M; Angeletti M; Markarian S; Shilajyan H; Antonyan A
Biophys Chem; 2022 Jul; 286():106820. PubMed ID: 35468399
[TBL] [Abstract][Full Text] [Related]
8. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224
[TBL] [Abstract][Full Text] [Related]
10. 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis.
Ludwig K; Fan H; Dobers J; Berger M; Reutter W; Böttcher C
Biochem Biophys Res Commun; 2004 Jan; 313(2):223-9. PubMed ID: 14684150
[TBL] [Abstract][Full Text] [Related]
11. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
[TBL] [Abstract][Full Text] [Related]
13. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26.
Eltzschig HK; Faigle M; Knapp S; Karhausen J; Ibla J; Rosenberger P; Odegard KC; Laussen PC; Thompson LF; Colgan SP
Blood; 2006 Sep; 108(5):1602-10. PubMed ID: 16670267
[TBL] [Abstract][Full Text] [Related]
14. Complex of dipeptidyl peptidase II with adenosine deaminase.
Sharoyan SG; Antonyan AA; Mardanyan SS; Lupidi G; Cuccioloni M; Angeletti M; Cristalli G
Biochemistry (Mosc); 2008 Aug; 73(8):943-9. PubMed ID: 18774942
[TBL] [Abstract][Full Text] [Related]
15. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution of adenosine deaminase and adenosine deaminase-complexing protein in rabbit kidney: implications for adenosine metabolism.
Schrader WP; West CA; Rudofsky UH; Samsonoff WA
J Histochem Cytochem; 1994 Jun; 42(6):775-82. PubMed ID: 8189039
[TBL] [Abstract][Full Text] [Related]
17. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
18. Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain.
Beraudi A; Traversa U; Villani L; Sekino Y; Nagy JI; Poli A
Neurochem Int; 2003 May; 42(6):455-64. PubMed ID: 12547644
[TBL] [Abstract][Full Text] [Related]
19. Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.
Gonzalez-Gronow M; Hershfield MS; Arredondo-Vega FX; Pizzo SV
J Biol Chem; 2004 May; 279(20):20993-8. PubMed ID: 15016824
[TBL] [Abstract][Full Text] [Related]
20. Adenosine deaminase in cell transformation. Biophysical manifestation of membrane dynamics.
Porat N; Gill D; Parola AH
J Biol Chem; 1988 Oct; 263(29):14608-11. PubMed ID: 2844778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]